skip to main content

S. 2917 (113th): Adding Ebola to the FDA Priority Review Voucher Program Act

The text of the bill below is as of Nov 19, 2014 (Reported by Senate Committee).


Calendar No. 602


2d Session

S. 2917


November 12, 2014

(for himself, Mr. Alexander, Ms. Mikulski, Mr. Enzi, Mrs. Murray, Mr. Burr, Mr. Casey, Mr. Isakson, Mrs. Hagan, Mr. Hatch, Mr. Franken, Mr. Roberts, Mr. Bennet, Mr. Kirk, Mr. Whitehouse, Mr. Scott, Ms. Baldwin, Mr. Murphy, Ms. Warren, Ms. Klobuchar, Mr. Blumenthal, Mr. Markey, Mr. Brown, Mr. Coburn, Ms. Collins, Mr. Durbin, Mr. Kaine, Mr. Blunt, Ms. Ayotte, Mrs. Boxer, Mr. Vitter, Mr. Cornyn, Mr. McConnell, Mr. Coons, Mr. Schumer, Mr. Moran, Mr. Portman, Mr. Booker, Mrs. Feinstein, Ms. Murkowski, Mr. Chambliss, Mr. Warner, Mrs. Gillibrand, Ms. Stabenow, Mr. Heinrich, and Mrs. Shaheen) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

November 19, 2014

Reported by , without amendment


To expand the program of priority review to encourage treatments for tropical diseases.


Short title

This Act may be cited as the Adding Ebola to the FDA Priority Review Voucher Program Act .


Priority review to encourage treatments for tropical diseases

Section 524 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360n ) is amended—


in subsection (a)(3)—


by redesignating subparagraph (Q) as subparagraph (R);


by inserting after subparagraph (P) the following:



; and


in subparagraph (R), as so redesignated, by striking regulation by and inserting order of; and


in subsection (b)—


in paragraph (2), by adding There is no limit on the number of times a priority review voucher may be transferred before such voucher is used. after the period at the end; and


in paragraph (4), by striking 365 days and inserting 90 days.

November 19, 2014

Reported without amendment